{"transactions":[{"id":707444,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:33:09.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084439","document":"tm2620629-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084439/tm2620629-6_4seq1.xml","form_type":"4"}},{"id":707443,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:32:38.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084438","document":"tm2620629-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084438/tm2620629-5_4seq1.xml","form_type":"4"}},{"id":707442,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:32:05.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084437","document":"tm2620629-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084437/tm2620629-4_4seq1.xml","form_type":"4"}},{"id":707441,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":2672,"kind":"person","name":"Melincoff Gwen A","position":1,"cik":"0001614890","reported_name":"Melincoff Gwen A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:31:28.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084435","document":"tm2620629-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084435/tm2620629-3_4seq1.xml","form_type":"4"}},{"id":707440,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:31:01.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084434","document":"tm2620629-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084434/tm2620629-2_4seq1.xml","form_type":"4"}},{"id":707431,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T12:30:14.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2026, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-07-15","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-084433","document":"tm2620629-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926084433/tm2620629-1_4seq1.xml","form_type":"4"}},{"id":827690,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-27T00:01:00.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as to 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.86,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-26-035403","document":"tm269848-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926035403/tm269848-2_4seq1.xml","form_type":"4"}},{"id":827689,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55914,"kind":"person","name":"Fuggetta Gianluca","position":1,"cik":"0001958188","reported_name":"Fuggetta Gianluca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-27T00:00:11.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":1.86,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-26-035400","document":"tm269848-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465926035400/tm269848-1_4seq1.xml","form_type":"4"}},{"id":1101989,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:23.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016541/ownership.xml","form_type":"4"}},{"id":1101988,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:22.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016535/ownership.xml","form_type":"4"}},{"id":1101987,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:20.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016540","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016540/ownership.xml","form_type":"4"}},{"id":1101986,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:19.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016537/ownership.xml","form_type":"4"}},{"id":1101985,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:17.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016539","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016539/ownership.xml","form_type":"4"}},{"id":1101984,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:14.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016536/ownership.xml","form_type":"4"}},{"id":1101983,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":2672,"kind":"person","name":"Melincoff Gwen A","position":1,"cik":"0001614890","reported_name":"Melincoff Gwen A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-25T21:30:13.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001641172-25-016538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000164117225016538/ownership.xml","form_type":"4"}},{"id":1195079,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55914,"kind":"person","name":"Fuggetta Gianluca","position":1,"cik":"0001958188","reported_name":"Fuggetta Gianluca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-22T00:00:09.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.29,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-011179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315225011179/ownership.xml","form_type":"4"}},{"id":1195078,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-22T00:00:04.000Z","date":"2025-03-20","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as to 25% on March 20, 2026, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.29,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-25-011175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315225011175/ownership.xml","form_type":"4"}},{"id":1309009,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, President"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-08T02:00:08.000Z","date":"2025-01-06","kind":"grant","planned":false,"acquired":true,"shares":271325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as to 25% on January 6, 2026 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":271325,"derivative":{"exercise_price":2.44,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":271325},"source":{"system":"sec-edgar","filing":"0001493152-25-001281","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315225001281/ownership.xml","form_type":"4"}},{"id":1436331,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Interim CEO"}}],"security":"Common Stock","published_at":"2024-08-12T21:23:31.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":14400,"price":1.01,"value":14544.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.98 to $1.07 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":14400,"source":{"system":"sec-edgar","filing":"0001493152-24-031378","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224031378/ownership.xml","form_type":"4"}},{"id":1436327,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-08-12T21:23:30.000Z","date":"2024-08-09","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.9988,"value":49940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.9814 to $1.00 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-24-031377","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224031377/ownership.xml","form_type":"4"}},{"id":1466537,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:00:27.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":1.21,"value":14520.0,"ownership":{"direct":true},"balance_after":289629,"source":{"system":"sec-edgar","filing":"0001493152-24-025831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025831/ownership.xml","form_type":"4"}},{"id":1466536,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-01T21:00:27.000Z","date":"2024-07-01","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.23,"value":6150.0,"ownership":{"direct":true},"balance_after":277629,"source":{"system":"sec-edgar","filing":"0001493152-24-025831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025831/ownership.xml","form_type":"4"}},{"id":1469121,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:12.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025342","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025342/ownership.xml","form_type":"4"}},{"id":1469119,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":2672,"kind":"person","name":"Melincoff Gwen A","position":1,"cik":"0001614890","reported_name":"Melincoff Gwen A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:11.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025341","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025341/ownership.xml","form_type":"4"}},{"id":1469118,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:09.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025339/ownership.xml","form_type":"4"}},{"id":1469117,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:08.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025336","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025336/ownership.xml","form_type":"4"}},{"id":1469120,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:07.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025338","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025338/ownership.xml","form_type":"4"}},{"id":1469116,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:07.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025335","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025335/ownership.xml","form_type":"4"}},{"id":1469115,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-27T01:30:06.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.29,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-24-025337","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224025337/ownership.xml","form_type":"4"}},{"id":1546142,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55915,"kind":"person","name":"Mack Gene","position":1,"cik":"0001737979","reported_name":"Mack Gene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-04-08T23:44:54.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on April 8, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":3.56,"expiration_date":"2034-04-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-24-013983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224013983/ownership.xml","form_type":"4"}},{"id":1556958,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:01:37.000Z","date":"2024-03-28","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.859,"value":115770.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7098 to $3.924, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001493152-24-012340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224012340/ownership.xml","form_type":"4"}},{"id":1558880,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":6376,"derivative":{"underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558879,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":8250,"derivative":{"underlying":"Common Stock","underlying_shares":249},"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558878,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":56250,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558877,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":6085,"price":4.06,"value":24705.1,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."}],"balance_after":21140,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558876,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":27225,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558875,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":26588,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558874,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":25763,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1562525,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55914,"kind":"person","name":"Fuggetta Gianluca","position":1,"cik":"0001958188","reported_name":"Fuggetta Gianluca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remark"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-26T01:30:15.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.37,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-24-011216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011216/ownership.xml","form_type":"4"}},{"id":1562526,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-26T01:30:11.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":370000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":370000,"derivative":{"exercise_price":4.37,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":370000},"source":{"system":"sec-edgar","filing":"0001493152-24-011215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011215/ownership.xml","form_type":"4"}},{"id":1701461,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-22T21:17:28.000Z","date":"2023-12-20","kind":"exercise","planned":false,"acquired":false,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":7013,"derivative":{"underlying":"Common Stock","underlying_shares":637},"source":{"system":"sec-edgar","filing":"0001209191-23-059558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123059558/doc4.xml","form_type":"4"}},{"id":1701460,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-22T21:17:28.000Z","date":"2023-12-21","kind":"sale","planned":false,"acquired":false,"shares":206,"price":2.46,"value":506.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4602 to $2.485 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5286,"source":{"system":"sec-edgar","filing":"0001209191-23-059558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123059558/doc4.xml","form_type":"4"}},{"id":1701459,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-22T21:17:28.000Z","date":"2023-12-20","kind":"exercise","planned":false,"acquired":true,"shares":637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":5492,"source":{"system":"sec-edgar","filing":"0001209191-23-059558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123059558/doc4.xml","form_type":"4"}},{"id":1711498,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-14T21:01:11.000Z","date":"2023-12-07","kind":"sale","planned":false,"acquired":false,"shares":1820,"price":2.5,"value":4550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares sold to cover withholding taxes incurred upon the vesting and settlement of restricted stock units in a trade that was initiated by the Issuer on the Reporting Person's behalf."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.48 to $2.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote."}],"balance_after":4855,"source":{"system":"sec-edgar","filing":"0001104659-23-126020","document":"tm2332941-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923126020/tm2332941-1_4seq1.xml","form_type":"4"}},{"id":1768882,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-03T20:36:35.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":9075,"derivative":{"underlying":"Common Stock","underlying_shares":825},"source":{"system":"sec-edgar","filing":"0001209191-23-051502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123051502/doc4.xml","form_type":"4"}},{"id":1768881,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:36:35.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":6675,"source":{"system":"sec-edgar","filing":"0001209191-23-051502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123051502/doc4.xml","form_type":"4"}},{"id":1775037,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-09-22T20:34:38.000Z","date":"2023-09-20","kind":"exercise","planned":false,"acquired":false,"shares":54900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested fully on September 20, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested fully on September 20, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":54900},"source":{"system":"sec-edgar","filing":"0001209191-23-050380","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123050380/doc4.xml","form_type":"4"}},{"id":1775036,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-22T20:34:38.000Z","date":"2023-09-20","kind":"exercise","planned":false,"acquired":true,"shares":54900,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":272629,"source":{"system":"sec-edgar","filing":"0001209191-23-050380","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123050380/doc4.xml","form_type":"4"}},{"id":1775035,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-22T20:34:17.000Z","date":"2023-09-20","kind":"exercise","planned":false,"acquired":false,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":7650,"derivative":{"underlying":"Common Stock","underlying_shares":2550},"source":{"system":"sec-edgar","filing":"0001209191-23-050379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123050379/doc4.xml","form_type":"4"}},{"id":1775034,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-22T20:34:17.000Z","date":"2023-09-20","kind":"exercise","planned":false,"acquired":true,"shares":2550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":5850,"source":{"system":"sec-edgar","filing":"0001209191-23-050379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123050379/doc4.xml","form_type":"4"}},{"id":1837893,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:18:04.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":9900,"derivative":{"underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001209191-23-041027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123041027/doc4.xml","form_type":"4"}},{"id":1837892,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:18:04.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":3300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":3300,"source":{"system":"sec-edgar","filing":"0001209191-23-041027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123041027/doc4.xml","form_type":"4"}},{"id":1844593,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:40:01.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039726","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039726/doc4.xml","form_type":"4"}},{"id":1844594,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:39:25.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039725/doc4.xml","form_type":"4"}},{"id":1844592,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:38:35.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039723/doc4.xml","form_type":"4"}},{"id":1844591,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":2672,"kind":"person","name":"Melincoff Gwen A","position":1,"cik":"0001614890","reported_name":"Melincoff Gwen A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:38:09.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039721/doc4.xml","form_type":"4"}},{"id":1844589,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:37:33.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039720/doc4.xml","form_type":"4"}},{"id":1844590,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-26T20:36:57.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 equal monthly installments commencing on July 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":10500,"derivative":{"exercise_price":4.5,"expiration_date":"2033-06-23","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-23-039719","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123039719/doc4.xml","form_type":"4"}},{"id":1921332,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":114523,"kind":"person","name":"Ballantyne Charles Evan","position":1,"cik":"0001371742","reported_name":"Ballantyne Charles Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-04-12T21:36:02.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest upon the board of directors' certification of the Issuer's share price reaching $10.00 per share based on the 10-day volume weighted average share price, subject to Reporting Person's continuous service through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest upon the board of directors' certification of the Issuer's share price reaching $10.00 per share based on the 10-day volume weighted average share price, subject to Reporting Person's continuous service through such vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-024125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123024125/doc4.xml","form_type":"4"}},{"id":1921331,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":114523,"kind":"person","name":"Ballantyne Charles Evan","position":1,"cik":"0001371742","reported_name":"Ballantyne Charles Evan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T21:36:02.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on April 10, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":4.79,"expiration_date":"2033-04-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-024125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123024125/doc4.xml","form_type":"4"}},{"id":1938367,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-27T21:28:43.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-021260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021260/doc4.xml","form_type":"4"}},{"id":1938366,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-27T21:28:43.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-021260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021260/doc4.xml","form_type":"4"}},{"id":1938365,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":55914,"kind":"person","name":"Fuggetta Gianluca","position":1,"cik":"0001958188","reported_name":"Fuggetta Gianluca","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-27T21:27:29.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-021258","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021258/doc4.xml","form_type":"4"}},{"id":1938364,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-27T21:26:54.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-021257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021257/doc4.xml","form_type":"4"}},{"id":1938363,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-27T21:26:54.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-021257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021257/doc4.xml","form_type":"4"}},{"id":2152996,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-22T20:14:52.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":54900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date."}],"balance_after":54900,"derivative":{"underlying":"Common Stock","underlying_shares":54900},"source":{"system":"sec-edgar","filing":"0001209191-22-051014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051014/doc4.xml","form_type":"4"}},{"id":2152995,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-22T20:14:52.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":329400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest fully on September 20, 2023, subject to Reporting Person's continuous service through such date."}],"balance_after":329400,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":329400},"source":{"system":"sec-edgar","filing":"0001209191-22-051014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051014/doc4.xml","form_type":"4"}},{"id":2152994,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29907,"kind":"person","name":"Islam Khalid","position":1,"cik":"0001701858","reported_name":"Islam Khalid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:13:28.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051012/doc4.xml","form_type":"4"}},{"id":2152993,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29906,"kind":"person","name":"Riley Jeffrey Scott","position":1,"cik":"0001487645","reported_name":"Riley Jeffrey Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:11:49.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051011/doc4.xml","form_type":"4"}},{"id":2153014,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29909,"kind":"person","name":"GOLDSTEIN DOV A MD","position":1,"cik":"0001120478","reported_name":"GOLDSTEIN DOV A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:10:45.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051010/doc4.xml","form_type":"4"}},{"id":2152992,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":2672,"kind":"person","name":"Melincoff Gwen A","position":1,"cik":"0001614890","reported_name":"Melincoff Gwen A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:09:23.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051009","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051009/doc4.xml","form_type":"4"}},{"id":2152991,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29908,"kind":"person","name":"Nicaise Claude","position":1,"cik":"0001644162","reported_name":"Nicaise Claude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:08:24.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051007/doc4.xml","form_type":"4"}},{"id":2152990,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":29905,"kind":"person","name":"HASLER HANS PETER","position":1,"cik":"0001226286","reported_name":"HASLER HANS PETER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-22T20:07:41.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer."}],"balance_after":10500,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-22-051005","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051005/doc4.xml","form_type":"4"}},{"id":2152989,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-22T20:06:47.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":10200,"derivative":{"underlying":"Common Stock","underlying_shares":10200},"source":{"system":"sec-edgar","filing":"0001209191-22-051003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051003/doc4.xml","form_type":"4"}},{"id":2152988,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-22T20:06:47.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":60900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on September 20, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":60900,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":60900},"source":{"system":"sec-edgar","filing":"0001209191-22-051003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051003/doc4.xml","form_type":"4"}},{"id":2205750,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-19T20:37:54.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":9900,"derivative":{"underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0001209191-22-042572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042572/doc4.xml","form_type":"4"}},{"id":2205749,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T20:37:54.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":59400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on July 1, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":59400,"derivative":{"exercise_price":4.01,"expiration_date":"2032-07-15","underlying":"Common Stock","underlying_shares":59400},"source":{"system":"sec-edgar","filing":"0001209191-22-042572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042572/doc4.xml","form_type":"4"}},{"id":2205748,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-19T20:36:48.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":13200,"derivative":{"underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0001209191-22-042571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042571/doc4.xml","form_type":"4"}},{"id":2205747,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T20:36:48.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on July 1, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":79200,"derivative":{"exercise_price":4.01,"expiration_date":"2032-07-15","underlying":"Common Stock","underlying_shares":79200},"source":{"system":"sec-edgar","filing":"0001209191-22-042571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042571/doc4.xml","form_type":"4"}},{"id":2254253,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common stock","published_at":"2022-05-27T20:10:32.000Z","date":"2022-05-25","kind":"purchase","acquired":true,"shares":2482,"price":2.58,"value":6403.56,"ownership":{"direct":true},"balance_after":217729,"source":{"system":"sec-edgar","filing":"0001415889-22-005798","document":"form4-05272022_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005798/form4-05272022_040501.xml","form_type":"4"}},{"id":2260743,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2022-05-23T20:41:38.000Z","date":"2022-05-20","kind":"purchase","acquired":true,"shares":9256,"price":2.83,"value":26194.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.75 to $2.97 inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":215247,"source":{"system":"sec-edgar","filing":"0001415889-22-005501","document":"form4-05232022_010526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005501/form4-05232022_010526.xml","form_type":"4"}},{"id":2260742,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common stock","published_at":"2022-05-23T20:41:38.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":4000,"price":2.71,"value":10840.0,"ownership":{"direct":true},"balance_after":205991,"source":{"system":"sec-edgar","filing":"0001415889-22-005501","document":"form4-05232022_010526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005501/form4-05232022_010526.xml","form_type":"4"}},{"id":2260741,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-05-23T20:00:47.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":3000,"price":2.7,"value":8100.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-22-005491","document":"form4a-05232022_040535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005491/form4a-05232022_040535.xml","form_type":"4/A","original_submission_date":"2022-05-19"}},{"id":2264511,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-05-19T21:00:20.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":3000,"price":8100,"value":24300000.0,"ownership":{"direct":true},"source":{"system":"sec-edgar","filing":"0001415889-22-005317","document":"form4-05192022_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005317/form4-05192022_050501.xml","form_type":"4"}},{"id":2293063,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-21T20:50:22.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":4922,"price":7.866,"value":38716.452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 filed on August 17, 2021 incorrectly listed the transaction code at \"M\" instead of \"P\"."}],"balance_after":216820,"source":{"system":"sec-edgar","filing":"0001209191-22-025180","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122025180/doc4a.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2458097,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2021-12-28T21:30:21.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":200000,"price":5.86,"value":1172000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 options shall vest on 10/15/2022 (the \"Initial Vesting Date\") and the remaining 150,000 options shall vest in a series of thirty-six (36) successive equal monthly installments on each subsequent monthly anniversary of the Initial Vesting Date."}],"balance_after":200000,"derivative":{"exercise_price":5.86,"exercise_date":"2022-10-15","expiration_date":"2032-10-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-21-006258","document":"form4-12282021_041202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588921006258/form4-12282021_041202.xml","form_type":"4"}},{"id":2601161,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":78153,"kind":"person","name":"RICHMAN ERIC I","position":1,"cik":"0001313876","reported_name":"RICHMAN ERIC I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-18T01:03:42.000Z","date":"2021-08-16","kind":"exercise","acquired":true,"shares":4922,"price":7.866,"value":38716.452,"ownership":{"direct":true},"balance_after":216820,"source":{"system":"sec-edgar","filing":"0001104659-21-107121","document":"tm2125355-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465921107121/tm2125355-1_4seq1.xml","form_type":"4"}}]}